Blue Owl Capital Holdings »

Engene Holdings shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Engene Holdings (ENGNW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $404k 475k 0.85

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
BVF
Highbridge Capital Management
Blue Owl Capital Holdings
Omega Fund Management
Calamos Advisors
Saba Capital Management
Polar Securities
CNH Partners
Tenor Capital Management
D. E. Shaw & Co
Millennium Management
Atalaya Capital Management
Marshall Wace
Exos TFP Holdings

View all funds holding Engene Holdings